These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 32244950

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison between integrated continuous direct compression line and batch processing - The effect of raw material properties.
    Karttunen AP, Wikström H, Tajarobi P, Fransson M, Sparén A, Marucci M, Ketolainen J, Folestad S, Korhonen O, Abrahmsén-Alami S.
    Eur J Pharm Sci; 2019 May 15; 133():40-53. PubMed ID: 30862514
    [Abstract] [Full Text] [Related]

  • 3. Development of a continuous direct compression platform for low-dose drug products.
    Van Snick B, Holman J, Vanhoorne V, Kumar A, De Beer T, Remon JP, Vervaet C.
    Int J Pharm; 2017 Aug 30; 529(1-2):329-346. PubMed ID: 28684361
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Continuous manufacturing of extended release tablets via powder mixing and direct compression.
    Ervasti T, Simonaho SP, Ketolainen J, Forsberg P, Fransson M, Wikström H, Folestad S, Lakio S, Tajarobi P, Abrahmsén-Alami S.
    Int J Pharm; 2015 Nov 10; 495(1):290-301. PubMed ID: 26320548
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Continuous direct compression: Development of an empirical predictive model and challenges regarding PAT implementation.
    Bekaert B, Van Snick B, Pandelaere K, Dhondt J, Di Pretoro G, De Beer T, Vervaet C, Vanhoorne V.
    Int J Pharm X; 2022 Dec 10; 4():100110. PubMed ID: 35024605
    [Abstract] [Full Text] [Related]

  • 9. Parameter optimization in a continuous direct compression process of commercially batch-produced bisoprolol tablets.
    Lyytikäinen J, Stasiak P, Kubelka T, Olenius T, Korhonen O, Ketolainen J, Ervasti T.
    Int J Pharm; 2022 Nov 25; 628():122355. PubMed ID: 36341918
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lubricant based determination of design space for continuously manufactured high dose paracetamol tablets.
    Taipale-Kovalainen K, Karttunen AP, Ketolainen J, Korhonen O.
    Eur J Pharm Sci; 2018 Mar 30; 115():1-10. PubMed ID: 29277668
    [Abstract] [Full Text] [Related]

  • 14. Particle Engineering of Excipients for Direct Compression: Understanding the Role of Material Properties.
    Mangal S, Meiser F, Morton D, Larson I.
    Curr Pharm Des; 2015 Mar 30; 21(40):5877-89. PubMed ID: 26446468
    [Abstract] [Full Text] [Related]

  • 15. Systematic development of a high dosage formulation to enable direct compression of a poorly flowing API: A case study.
    Schaller BE, Moroney KM, Castro-Dominguez B, Cronin P, Belen-Girona J, Ruane P, Croker DM, Walker GM.
    Int J Pharm; 2019 Jul 20; 566():615-630. PubMed ID: 31158454
    [Abstract] [Full Text] [Related]

  • 16. Batch vs. continuous direct compression - a comparison of material processability and final tablet quality.
    Bekaert B, Janssen PHM, Fathollahi S, Vanderroost D, Roelofs T, Dickhoff BHJ, Vervaet C, Vanhoorne V.
    Int J Pharm X; 2024 Jun 20; 7():100226. PubMed ID: 38235316
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.